carbostyril has been researched along with Chemical Dependence in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (11.76) | 18.2507 |
2000's | 9 (52.94) | 29.6817 |
2010's | 6 (35.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bennett, JA; Lile, JA; Rush, CR; Sevak, RJ; Stoops, WW | 1 |
Azorin, JM; Camus, V; Costentin, J; Crocq, MA; Daléry, J; Gliskman, J; Krebs, MO; Limosin, F; Millet, B | 1 |
Anderson, SJ; Brady, KT; McRae, AL; Tolliver, BK; Verduin, ML | 1 |
Elkashef, A; Hanson, G; Tiihonen, J; Vocci, F; White, J; Wickes, W | 1 |
Bergman, J | 1 |
Lai, CH | 1 |
Glaser, PE; Hays, LR; Lile, JA; Rush, CR; Stoops, WW | 1 |
Cottencin, O; Geoffroy, PA; Goddefroy, G; Rolland, B | 1 |
Brunetti, M; Dezi, S; Di Tizio, L; Grandinetti, P; Martinotti, G; Pozzi, G | 1 |
Gyertyán, I; Kiss, B; Román, V; Sághy, K; Szombathelyi, Z | 1 |
Beard, L; Brown, ES; Garza, M; Jeffress, J; Liggin, JD | 1 |
Glaser, PE; Lile, JA; Rush, CR; Stoops, WW | 1 |
Kantrowitz, JT; Srihari, VH; Tek, C | 1 |
Arnold, KK; Yager, J | 1 |
Gardner, TJ; Kosten, TR | 1 |
Feinberg, SS | 1 |
Guelpa, G; Hammann, C | 1 |
4 review(s) available for carbostyril and Chemical Dependence
Article | Year |
---|---|
[Clinical potentialities and perspectives for the use of aripiprazole in other disorders than its classical indications. A critical analysis of the recent literature].
Topics: Aged; Alzheimer Disease; Antipsychotic Agents; Aripiprazole; Borderline Personality Disorder; Depressive Disorder, Major; Humans; Mental Disorders; Neurodegenerative Diseases; Parkinson Disease; Piperazines; Quinolones; Schizophrenia; Substance-Related Disorders; Tourette Syndrome | 2008 |
Pharmacotherapy of methamphetamine addiction: an update.
Topics: Antipsychotic Agents; Aripiprazole; Bupropion; Central Nervous System Stimulants; Dextroamphetamine; Drug Therapy; Humans; Lobeline; Methamphetamine; Methylphenidate; Narcotic Antagonists; Nicotinic Agonists; Piperazines; Prevalence; Quinolones; Recurrence; Substance-Related Disorders | 2008 |
Medications for stimulant abuse: agonist-based strategies and preclinical evaluation of the mixed-action D-sub-2 partial agonist aripiprazole (Abilify).
Topics: Animals; Antipsychotic Agents; Aripiprazole; Central Nervous System Stimulants; Dopamine Agonists; Drug Evaluation, Preclinical; Haplorhini; Humans; Piperazines; Quinolones; Receptors, Dopamine D2; Self Administration; Substance-Related Disorders | 2008 |
Aripiprazole, alcohol and substance abuse: a review.
Topics: Alcoholism; Antipsychotic Agents; Aripiprazole; Cocaine-Related Disorders; Humans; Piperazines; Quinolones; Substance-Related Disorders; Tobacco Use Disorder | 2012 |
1 trial(s) available for carbostyril and Chemical Dependence
Article | Year |
---|---|
Switching outpatients with bipolar or schizoaffective disorders and substance abuse from their current antipsychotic to aripiprazole.
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Comorbidity; Diagnosis, Dual (Psychiatry); Dopamine Agonists; Female; Humans; Male; Pilot Projects; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quinolones; Receptors, Dopamine D2; Substance-Related Disorders; Treatment Outcome | 2005 |
12 other study(ies) available for carbostyril and Chemical Dependence
Article | Year |
---|---|
Influence of aripiprazole pretreatment on the reinforcing effects of methamphetamine in humans.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Aripiprazole; Blood Pressure; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Heart Rate; Humans; Male; Methamphetamine; Piperazines; Quinolones; Reinforcement, Psychology; Self Administration; Substance-Related Disorders; Surveys and Questionnaires; Young Adult | 2013 |
Reversible elevation of triglycerides in dual-diagnosis patients taking aripiprazole: a case series.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Diagnosis, Dual (Psychiatry); Humans; Hypertriglyceridemia; Mental Disorders; Piperazines; Quinolones; Substance-Related Disorders; Triglycerides; Weight Gain | 2008 |
Olanzapine abuse was relieved after switching to aripiprazole in a patient with psychotic depression.
Topics: Affective Disorders, Psychotic; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Female; Humans; Middle Aged; Olanzapine; Piperazines; Quinolones; Substance-Related Disorders | 2010 |
Discriminative stimulus, subject-rated and cardiovascular effects of cocaine alone and in combination with aripiprazole in humans.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Behavior; Blood Pressure; Cardiovascular System; Central Nervous System Stimulants; Cocaine; Dextroamphetamine; Discrimination Learning; Female; Heart Rate; Humans; Male; Middle Aged; Piperazines; Quinolones; Substance-Related Disorders; Surveys and Questionnaires | 2011 |
Efficacy of aripiprazole in comorbid addiction in bipolar disorder.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Humans; Male; Piperazines; Quinolones; Substance-Related Disorders; Treatment Outcome | 2012 |
Cariprazine (RGH-188), a D₃-preferring dopamine D₃/D₂ receptor partial agonist antipsychotic candidate demonstrates anti-abuse potential in rats.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Benzoxazoles; Cocaine-Related Disorders; Dopamine Agonists; Dose-Response Relationship, Drug; Haloperidol; Male; Piperazines; Quinolones; Rats; Rats, Long-Evans; Receptors, Dopamine D2; Secondary Prevention; Substance-Related Disorders | 2013 |
A low dose of aripiprazole attenuates the subject-rated effects of d-amphetamine.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Blood Pressure; Central Nervous System Stimulants; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Heart Rate; Humans; Male; Piperazines; Quinolones; Substance-Related Disorders; Surveys and Questionnaires | 2006 |
Resolution of tardive dyskinesia after addition of aripiprazole to haloperidol depot.
Topics: Antipsychotic Agents; Aripiprazole; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Haloperidol; Humans; Male; Middle Aged; Piperazines; Quinolones; Remission Induction; Schizophrenia; Substance-Related Disorders | 2007 |
A case of unexpected and selective remission of a 20-year history of ephedrine dependence following treatment with low-dose aripiprazole.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Depressive Disorder, Major; Drug Administration Schedule; Drug Therapy, Combination; Ephedrine; Feeding and Eating Disorders; Female; Fluoxetine; Humans; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors; Substance-Related Disorders | 2007 |
Human laboratory and neuroimaging studies in substance use disorders: developing new treatment approaches.
Topics: Amphetamine-Related Disorders; Antipsychotic Agents; Aripiprazole; Brain; Cocaine-Related Disorders; Diffusion Magnetic Resonance Imaging; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Piperazines; Quinolones; Substance-Related Disorders | 2007 |
Fluoroquinolone-induced depression.
Topics: Adult; Anti-Infective Agents; Depressive Disorder; Female; Fluoroquinolones; Humans; Quinolones; Substance-Related Disorders; Urinary Tract Infections | 1995 |
[Drug-induced calculi].
Topics: Allopurinol; Antacids; Ascorbic Acid; Calcium; Cathartics; Ceftriaxone; Humans; Kidney Calculi; Medical History Taking; Quinolones; Substance-Related Disorders; Sulfonamides | 1993 |